Literature DB >> 28355088

Temozolomide-Mediated Apoptotic Death Is Improved by Thymoquinone in U87MG Cell Line.

Mozafar Khazaei1, Mona Pazhouhi1.   

Abstract

Apoptosis induction of cancer cells can be an appropriate strategy by which chemotherapeutic agents kill tumor cells. The aim of the present study was to investigate the effect of temozolomide and thymoquinone combination on apoptotic pathway of human glioblastoma multiforme cell line (U87MG). U87MG cells were cultured, treated with temozolomide and thymoquinone, and cell proliferation was measured. Apoptosis cell death and its possible mechanism were investigated by various methods. Combination of temozolomide and thymoquinone had a synergistic effect on cells viability. Thymoquinone intensified the temozolomide-induced apoptosis. Combination of temozolomide and thymoquinone can be a good strategy for treatment of glioblastoma.

Entities:  

Keywords:  Glioblastoma multiforme; apoptosis; temozolomide; thymoquinone

Mesh:

Substances:

Year:  2017        PMID: 28355088     DOI: 10.1080/07357907.2017.1289383

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  11 in total

Review 1.  The multifaceted NF-kB: are there still prospects of its inhibition for clinical intervention in pediatric central nervous system tumors?

Authors:  Mariana Medeiros; Marina Ferreira Candido; Elvis Terci Valera; María Sol Brassesco
Journal:  Cell Mol Life Sci       Date:  2021-07-31       Impact factor: 9.261

Review 2.  Thymoquinone as a Potential Adjuvant Therapy for Cancer Treatment: Evidence from Preclinical Studies.

Authors:  A G M Mostofa; Md Kamal Hossain; Debasish Basak; Muhammad Shahdaat Bin Sayeed
Journal:  Front Pharmacol       Date:  2017-06-12       Impact factor: 5.810

Review 3.  Therapeutic Potential of Thymoquinone in Glioblastoma Treatment: Targeting Major Gliomagenesis Signaling Pathways.

Authors:  Fabliha Ahmed Chowdhury; Md Kamal Hossain; A G M Mostofa; Maruf Mohammad Akbor; Muhammad Shahdaat Bin Sayeed
Journal:  Biomed Res Int       Date:  2018-01-31       Impact factor: 3.411

4.  Evaluation of Hydro-Alcoholic Extract of Trifolium Pratens L. for Its Anti-Cancer Potential on U87MG Cell Line.

Authors:  Mozafar Khazaei; Mona Pazhouhi; Saber Khazaei
Journal:  Cell J       Date:  2018-05-15       Impact factor: 2.479

5.  Protective effect of hydroalcoholic extracts of Trifolium pratense L. on pancreatic β cell line (RIN-5F) against cytotoxicty of streptozotocin.

Authors:  Mozafar Khazaei; Mona Pazhouhi
Journal:  Res Pharm Sci       Date:  2018-08

6.  Microarray gene profiling analysis of glioblastoma cell line U87 reveals suppression of the FANCD2/Fanconi anemia pathway by the combination of Y15 and temozolomide.

Authors:  Zichuan Wang; Nan Chen; Jin Yang; Qingzhong Wang; Aimin Li
Journal:  Arch Med Sci       Date:  2019-06-20       Impact factor: 3.318

7.  Synergistic Anticancer Effect of Paclitaxel and Noscapine on Human Prostate Cancer Cell Lines.

Authors:  Arezou Rabzia; Mozafar Khazaei; Zahra Rashidi; Mohammad Rasoul Khazaei
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

8.  Involvement of NOS2 Activity on Human Glioma Cell Growth, Clonogenic Potential, and Neurosphere Generation.

Authors:  Paola Palumbo; Francesca Lombardi; Giuseppe Siragusa; Soheila Raysi Dehcordi; Sabino Luzzi; AnnaMaria Cimini; Maria Grazia Cifone; Benedetta Cinque
Journal:  Int J Mol Sci       Date:  2018-09-17       Impact factor: 5.923

9.  Anti-proliferative and cytotoxic effect of Iranian snake (Vipera raddei kurdistanica) venom on human breast cancer cells via reactive oxygen species-mediated apoptosis.

Authors:  Ehsan Malekara; Mona Pazhouhi; Iraj Rashidi; Cyrus Jalili
Journal:  Res Pharm Sci       Date:  2020-02-20

10.  Molecular mechanism of the anti-diabetic activity of an identified oligosaccharide from Rosa canina.

Authors:  Gholamreza Bahrami; Seyed Shahram Miraghaee; Bahar Mohammadi; Mohammad Taher Bahrami; Gholamreza Taheripak; Samira Keshavarzi; Atefeh Babaei; Soraya Sajadimajd; Razieh Hatami
Journal:  Res Pharm Sci       Date:  2020-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.